The Value of a Cure: Ensuring Access and Encouraging Innovation

External actions for this article

Innovations in medical research and technology have produced cures and breakthrough therapies to overcome diseases that were once considered a death sentence. Polio is preventable with a vaccine, HIV is managed with a daily drug regimen, and Hepatitis C now has a cure. But are these breakthroughs reaching all communities? How can we balance the high costs of drug development with affordability? And what can we do to ensure that new cures continue to be developed?

Following the passage of the long-awaited 21st Century Cures legislation, and at the start of a new Congress and new administration, join The Hill and the USC Schaeffer Center for a conversation with policymakers, health officials, industry representatives and patient advocates on the value of cures – their implications for society’s health and public expenditures, and the path forward.

Join the conversation by following @TheHillEvents and @SchaefferCenter and using: #ValueofaCure
Read a summary of the event here.

Event Date
Tuesday, February 28, 2017
8:00 AM - 10:30 AM Eastern
The Newseum
Knight Broadcast Studio
555 Pennsylvania Avenue, NW
Washington, DC


8:30 AM  Welcome
Johanna Derlega, Publisher, The Hill

8:35 AM  View from Capitol Hill

  • Rep. Diana DeGette (D-CO), Member, House Committee on Energy and Commerce
  • Rep. Fred Upton (R-MI), Former Chairman, House Committee on Energy and Commerce
  • Moderated by Bob Cusack, Editor-in-Chief, The Hill

9:00 AM Audience Q+A
9:10 AM  Sponsor Perspective, Presented by USC Schaeffer Center for Health Policy & Economics

  • Douglas Dieterich, MD, Director, Institute for Liver Medicine, Professor of Medicine, Division of Liver Diseases, Mount Sinai Health Systems
  • Timothy Wright, MD, Chief R&D Officer, Regulus Therapeutics
  • Moderated by Dana Goldman, PhD, Leonard D. Schaeffer Chair and a Distinguished Professor of Pharmacy, Public Policy & Economics, University of Southern California
9:30 AM Experts Panel
  • Georges Benjamin, MD, Executive Director, American Public Health Association
  • Garth Graham, MD, President, Aetna Foundation
  • Carmen Pastor, President, Fuerza Contra Alzheimer's
  • Moderated by: Peter Sullivan, Staff Writer, The Hill
10:00 AM Audience Q+A
10:05 AM  Closing
Johanna Derlega, Publisher, The Hill
Register Now The event you will register for is named The Value of a Cure: Ensuring Access and Encouraging Innovation